This inventor holds 1 USPTO granted patent. Top assignee: Guangdong University of Technology. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Shungquan Mu
Introduction
Shungquan Mu is a notable inventor based in Guangzhou, China. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of novel crystal forms of medications. His work emphasizes safety, efficiency, and environmental sustainability in drug preparation methods.
Latest Patents
Shungquan Mu holds a patent for "Crystal form F of trelagliptin and preparation method thereof." This innovative method involves adding a mediating protein to trelagliptin to create a mixture. A mechanochemical action is then introduced to transform the crystal form of trelagliptin into the novel crystal form F. This preparation method is advantageous as it does not require any organic solvents, thereby eliminating the risk of solvent residue that could compromise medication safety. Additionally, this method is less time-consuming than traditional solvent crystallization techniques, making it suitable for green industrial production. The characteristics of this method include simplicity, high efficiency, safety, and environmental friendliness.
Career Highlights
Shungquan Mu is affiliated with the Guangdong University of Technology, where he continues to contribute to research and innovation in the field of pharmaceuticals. His work not only advances scientific knowledge but also aims to improve the safety and efficacy of medications available to the public.
Collaborations
Shungquan Mu collaborates with esteemed colleagues such as Jierui Huo and Kailin Xu. Their combined expertise fosters a productive research environment that enhances the development of innovative solutions in pharmaceutical sciences.
Conclusion
Shungquan Mu's contributions to the field of pharmaceuticals through his innovative patent demonstrate his commitment to improving medication safety and efficiency. His work is a testament to the importance of innovation in the healthcare industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile